STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-04-19
Here’s whether Boston Scientific Corp. (BSX) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-7.42% over 10 days); weak 1-year return of -32.6%; 3-month momentum negative (-27.1%). Currently 41.3% off its 52-week high. Score: -6/7.
BSX is trading below its 200-day MA ($92.16) — a key warning sign the longer-term trend is under pressure. An RSI of 34.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -32.6% compares to +35.1% for SPY (trailed the market by 67.7%). The current 41.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $6,743 today
vs. S&P 500 (SPY) — same period trailed market by 67.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($92.16)
✗Above 50-day MA ($69.94)
✓RSI(14) neutral zone (30–70) — currently 34.8
✗Positive return (-32.6%)
!Within 10% of period high (−41.3%)
Period Range $64.23
$60.59$109.50
RSI (14) 34.8
0 · OversoldOverbought · 100
Key Metrics
Price$64.23
Period Return-32.6%
Period High$109.50
Period Low$60.59
Drawdown−41.3%
MA-50$69.94
MA-200$92.16
RSI (14)34.8
Avg Volume (30d)14.5M
vs. SPYtrailed by 67.7%
Return Rank#868 of 996
Trend Signals
Price is below the 200-day moving average ($92.16)